Wnt/β-catenin signaling pathway in liver biology and tumorigenesis
- PMID: 38379098
- DOI: 10.1007/s11626-024-00858-7
Wnt/β-catenin signaling pathway in liver biology and tumorigenesis
Abstract
The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway that controls fundamental physiological and pathological processes by regulating cell proliferation and differentiation. The Wnt/β-catenin pathway enables liver homeostasis by inducing differentiation and contributes to liver-specific features such as metabolic zonation and regeneration. In contrast, abnormalities in the Wnt/β-catenin pathway promote the development and progression of hepatocellular carcinoma (HCC). Similarly, hepatoblastoma, the most common childhood liver cancer, is frequently associated with β-catenin mutations, which activate Wnt/β-catenin signaling. HCCs with activation of the Wnt/β-catenin pathway have unique gene expression patterns and pathological and clinical features. Accordingly, they are highly differentiated with retaining hepatocyte-like characteristics and tumorigenic. Activation of the Wnt/β-catenin pathway in HCC also alters the state of immune cells, causing "immune evasion" with inducing resistance to immune checkpoint inhibitors, which have recently become widely used to treat HCC. Activated Wnt/β-catenin signaling exhibits these phenomena in liver tumorigenesis through the expression of downstream target genes, and the molecular basis is still poorly understood. In this review, we describe the physiological roles of Wnt/b-catenin signaling and then discuss their characteristic changes by the abnormal activation of Wnt/b-catenin signaling. Clarification of the mechanism would contribute to the development of therapeutic agents in the future.
Keywords: GREB1; HNF4α; Hepatoblastoma; Hepatocellular carcinoma; Wnt; β-Catenin.
© 2024. The Society for In Vitro Biology.
Similar articles
-
Calculus bovis in hepatocellular carcinoma: Tumor molecular basis, Wnt/β-catenin pathway role, and protective mechanism.World J Gastroenterol. 2024 Sep 21;30(35):3959-3964. doi: 10.3748/wjg.v30.i35.3959. World J Gastroenterol. 2024. PMID: 39351056 Free PMC article.
-
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.J Hepatol. 2018 Jun;68(6):1203-1213. doi: 10.1016/j.jhep.2017.12.018. Epub 2018 Mar 7. J Hepatol. 2018. PMID: 29525529
-
Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.J Hepatol. 2021 Mar;74(3):613-626. doi: 10.1016/j.jhep.2020.09.032. Epub 2020 Oct 8. J Hepatol. 2021. PMID: 33038431 Free PMC article.
-
β-Catenin signaling in hepatocellular carcinoma.J Clin Invest. 2022 Feb 15;132(4):e154515. doi: 10.1172/JCI154515. J Clin Invest. 2022. PMID: 35166233 Free PMC article. Review.
-
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.Semin Cancer Biol. 2011 Feb;21(1):44-58. doi: 10.1016/j.semcancer.2010.12.010. Epub 2010 Dec 21. Semin Cancer Biol. 2011. PMID: 21182948 Free PMC article. Review.
Cited by
-
Calculus bovis in hepatocellular carcinoma: Tumor molecular basis, Wnt/β-catenin pathway role, and protective mechanism.World J Gastroenterol. 2024 Sep 21;30(35):3959-3964. doi: 10.3748/wjg.v30.i35.3959. World J Gastroenterol. 2024. PMID: 39351056 Free PMC article.
-
Unlocking Hope: Therapeutic Advances and Approaches in Modulating the Wnt Pathway for Neurodegenerative Diseases.Mol Neurobiol. 2025 Mar;62(3):3630-3652. doi: 10.1007/s12035-024-04462-4. Epub 2024 Sep 23. Mol Neurobiol. 2025. PMID: 39313658 Free PMC article. Review.
-
Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications.J Clin Transl Hepatol. 2025 Apr 28;13(4):315-326. doi: 10.14218/JCTH.2024.00401. Epub 2025 Jan 14. J Clin Transl Hepatol. 2025. PMID: 40206274 Free PMC article. Review.
-
Natural compounds as regulators of miRNAs: exploring a new avenue for treating brain cancer.Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug;398(8):9551-9568. doi: 10.1007/s00210-025-03934-1. Epub 2025 Mar 6. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40047858 Review.
-
Reevaluating Calculus bovis: Modulating the liver cancer immune microenvironment via the Wnt/β-catenin pathway.World J Gastroenterol. 2025 Feb 14;31(6):99750. doi: 10.3748/wjg.v31.i6.99750. World J Gastroenterol. 2025. PMID: 39958448 Free PMC article.
References
-
- Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni N, Savall M, Bossard P, Sohier P, Drouet V, Tournier E, Dumont F, Sanson R, Calderaro J, Zucman-Rossi J, Vasseur-Cognet M, Just PA, Terris B, Perret C, Gilgenkrantz H (2018) AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. J Hepatol 68:1203–1213 - PubMed
-
- Adebayo Michael AO, Ko S, Tao J, Moghe A, Yang H, Xu M, Russell JO, Pradhan-Sundd T, Liu S, Singh S, Poddar M, Monga JS, Liu P, Oertel M, Ranganathan S, Singhi A, Rebouissou S, Zucman-Rossi J, Ribback S, Calvisi D, Qvartskhava N, Görg B, Häussinger D, Chen X, Monga SP (2019) Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations. Cell Metab 29:1135-1150.e1136 - PubMed
-
- Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP (2006) Activation of Wnt/β-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44:992–1002 - PubMed
-
- Armengol C, Cairo S, Fabre M, Buendia MA (2011) Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. Int J Biochem Cell Biol 43:265–270 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical